Case number 1:23-cv-00287
Exelixis, Inc. v. Cipla Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 5, 2023 | 13 | REDACTED VERSION of 9 Stipulation - by Exelixis, Inc.. (Raucci, Anthony) (Entered: 05/05/2023) (3) |
| May 4, 2023 | 9 | [SEALED] STIPULATION and [Proposed] Order to Stay All Proceedings by Exelixis, Inc.. (Raucci, Anthony) (Entered: 05/04/2023) (0) |
| May 4, 2023 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Cipla (EU Limited) for Cipla Ltd., Cipla USA, Inc. filed by Cipla Ltd., Cipla USA, Inc.. (Farnan, Kelly) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 11 | [SEALED] ORDER Granting 9 Stipulation and Proposed Order to Stay All Proceedings. Signed by Judge Richard G. Andrews on 5/4/2023.*This order has been emailed to local counsel. (nms) (Entered: 05/04/2023) (0) |
| May 4, 2023 | 12 | ORDER: The case is ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the related proceedings have been resolved so that this case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 5/4/2023. (nms) (Entered: 05/04/2023) (1) |
| Mar 22, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 03/22/2023) (0) |
| Mar 20, 2023 | 7 | WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla Ltd. waiver sent on 3/20/2023, answer due 5/19/2023. (Raucci, Anthony) (Entered: 03/20/2023) (1) |
| Mar 20, 2023 | 8 | WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla USA, Inc. waiver sent on 3/20/2023, answer due 5/19/2023. (Raucci, Anthony) (Entered: 03/20/2023) (1) |
| Mar 16, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023) (Main Document) (20) |
| Mar 16, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 03/17/2023) (3) |
| Mar 16, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 3, 2023. Date of Expiration of Patent: U.S. Patent No. 8,877,776 expires on October 8, 2030; U.S. Patent Nos. 11,091,439, 11,091,440 and 11,098,015 expire on January 15, 2030; and U.S. Patent No. 11,298,349 expires on February 10, 2032. Thirty Month Stay Deadline: 8/3/2025. (twk) (Entered: 03/17/2023) (1) |
| Mar 16, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2; 11,298,349 B2. (twk) (Entered: 03/17/2023) (1) |
| Mar 16, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (twk) (Entered: 03/17/2023) (1) |
| Mar 16, 2023 | 6 | Summons Issued as to Cipla Ltd., Cipla USA, Inc. on 3/17/2023. (Attachments: # 1 Summons Issued)(twk) (Entered: 03/17/2023) (Main Document) (2) |
| Mar 16, 2023 | 6 | Summons Issued as to Cipla Ltd., Cipla USA, Inc. on 3/17/2023. (Attachments: # 1 Summons Issued)(twk) (Entered: 03/17/2023) (Summons Issued) (2) |
| Mar 16, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023) (Exhibit A-E) (30) |
| Mar 16, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Ltd., Cipla USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4091291.) - filed by Exelixis, Inc. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(twk) (Entered: 03/17/2023) (Civil Cover Sheet) (2) |
